Star Therapeutics at a glance
As of- [1] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), October 23, 2026
- [2] Lead investors: Pulse 2.0, October 23, 2026
Is this your company? Get featured or correct your listing →
Recent changes
- Oct 23, 2026Oct 23, 2026Raised $200M Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: Catalio Capital Management Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: Cormorant Asset Management Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: RA Capital Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: New Leaf Venture Partners Pulse 2.0
Earlier changes (3)
- Oct 23, 2026Oct 23, 2026New investor: Janus Henderson Investors Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: OrbiMed Advisors Pulse 2.0
- Oct 23, 2026Oct 23, 2026Star Therapeutics Raises $200M From OrbiMed, Janus Henderson Pulse story
Funding history
1 equity event · newest first · sources dated per row| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2026 | Funding round | $200M | — | OrbiMed AdvisorsunverifiedJanus Henderson Investorsunverified WithAgent CapitalunverifiedCatalio Capital ManagementunverifiedCormorant Asset ManagementunverifiedNew Leaf Venture PartnersunverifiedRA CapitalunverifiedNYBC VenturesRedmileSofinnova InvestmentsSoleus Capital | Pulse 2.0Pulse story |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Investors
Latest Pulse
- Oct 25, 2026Zai Lab's $250M PIPE Shows How Biotechs Refill PipelinesNasdaq-listed Zai Lab raised about $250 million in a PIPE financing, selling 11.34 million shares at $22.04 each to fund its DLL3-targeting cancer drug, a reminder that public biotechs still lean on private placements between launches.→
- Oct 25, 2026Why Big Pharma Is Co-Leading AI Biotech Rounds NowBristol Myers Squibb led Pathos AI's $237M Series E and OrbiMed and Janus Henderson co-led Star Therapeutics' $200M round this week, a shift from pharma acquiring AI biotechs to funding them directly.→
- Oct 25, 2026Biotech's AI Bet: $687M Across Three Rounds In One WeekThree biotech financings announced in the same week pushed $687 million into AI-linked drug development, with OrbiMed and Janus Henderson among the investors doubling down on the sector.→
- Oct 25, 2026Bolt Biotherapeutics Buys Prana, Raises $120M For PRA-216Bolt Biotherapeutics acquired Prana Therapies in a stock-for-stock reverse merger and raised a concurrent $120 million private placement to advance Prana's lead bispecific antibody, PRA-216.→
- Oct 23, 2026Star Therapeutics Raises $200M From OrbiMed, Janus HendersonStar Therapeutics raised $200 million in private financing co-led by OrbiMed and Janus Henderson, a fresh vehicle from the biotech team whose last company, Vega Therapeutics, sold to Incyte for up to $2 billion in July.→
Coverage Timeline
newest firstAll Coverage
FUNDING$437M Combined
Why Big Pharma Is Co-Leading AI Biotech Rounds Now
Bristol Myers Squibb led Pathos AI's $237M Series E and OrbiMed and Janus Henderson co-led Star Therapeutics' $200M round this week, a shift from pharma acquiring AI biotechs to funding them directly.
DEEP DIVE
Star Therapeutics Raises $200M From OrbiMed, Janus Henderson
FUNDING$200M Private Financing
Star Therapeutics Raises $200M From OrbiMed, Janus Henderson
Star Therapeutics raised $200 million in private financing co-led by OrbiMed and Janus Henderson, a fresh vehicle from the biotech team whose last company, Vega Therapeutics, sold to Incyte for up to $2 billion in July.
DEEP DIVE
Value Add Research
Related Companies
Shared investors
Star Therapeutics FAQ
How much has Star Therapeutics raised?
Star Therapeutics has raised at least $200M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $200M funding round in October 2026, reported by Pulse 2.0. Debt financing, tender offers and secondary sales are not counted.
Who invested in Star Therapeutics?
Lead investors in Star Therapeutics's sourced funding rounds include OrbiMed Advisors and Janus Henderson Investors. Per round: its October 2026 funding round was led by OrbiMed Advisors and Janus Henderson Investors.
Sources & methodologyshow
Where these figures come from
- Pulse 2.0Value Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.